|
COVID-19: Blood cancer patients gain antibodies from vaccine booster - study
[JP] Blood cancer patients, already at high risk, often did not develop antibodies against COVID-19 from the first shot. But the booster and antibody therapy can provide a better shield.Many adults suffering from blood cancers who did not develop antibodies from their first dose of the COVID-19 vaccine managed to do so after receiving the booster shot, a new study has found. In addition, receiving antibody alongside the second dose can further shield patients from the virus. Patients suffering from blood cancers are at high risk of developing a severe case of the disease after being infected with the novel coronavirus SARS-CoV-2, which causes COVID-19. However, the fact that many do not develop immune responses to initial vaccination has raised concerns. The findings of this study, published in the peer-reviewed academic journal Cancer, raises hopes for protecting these high-risk cancer patients from the global pandemic. Posted by: Besoeker 2022-07-11 |
| http://www.rantburg.com/poparticle.php?ID=638153 |